Ruxolitinib/Pomalidomide combination therapy in myelofibrosis: Current data from the MPNSG-0212 trialF. Stegelmann,H. Hebart,M. Bangerter,D. Wolleschak,M. Griesshammer,S. Koschmieder,A. Hochhaus,F. Heidel,R. Moehle,A. Reiter,C. Scheid,N. von Bubnoff, R. Kirschbaum,R. Reim,U. Sutter,K. Vetter,H. Doehner,R. F. Schlenk,K. DoehnerONCOLOGY RESEARCH AND TREATMENT(2016)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要